Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Ann Surg Oncol. 2017 Jul 19;24(12):3502–3509. doi: 10.1245/s10434-017-6009-x

Figure 2.

Figure 2

Kaplan-Meier survival plots with risk tables of disease-specific survival for patients in the external validation cohort from the California Cancer Registry. (A) American Joint Committee on Cancer pathologic stage (PS); (B) pathologic stage plus grade (PS+G); (C) pathologic stage plus grade plus estrogen receptor status (PS+G+E); (D) pathologic stage plus grade plus estrogen receptor status plus HER2 status (PS+E+G+H); (E) T stage (T) + N stage (N); (F) T stage plus N stage plus grade (T+N+G); (G) T stage plus N stage plus grade plus estrogen receptor status (T+N+G+E); (H) T stage plus N stage plus grade plus estrogen receptor status plus HER2 status (T+N+G+E+H). Log-rank test is shown for each comparison.